BioTrinity, now in its 19th year, is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The two-day conference programme for 2025 features a dual track of showcase presentations from R&D companies at around the Series A stage, across 14 different therapy areas, a packed business & investment track, sponsors exhibition, networking events, private partnering meetings and an academic poster presentation.
After another sell-out year in 2024, we expect an expanded and refreshed audience of 900 delegates to attend BioTrinity 2025, comprising a mix of early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and a broad range of valued service providers. Delegates attend from the UK, Europe the U.S, Japan, China, Australia and beyond, and the team welcome discussion with clusters to discuss their delegation requirements.
Call for speakers
Email Jane O'Driscoll if you'd like to be considered for a speaking or presentation opportunity across any of the science or business sessions.
Science - track 1:
- Neuroscience
- Gene and cell therapy
- Immunology and inflammation
- Oncology
- Rare diseases
- AI for drug discovery
- AMR
- New platforms and technologies for drug discovery
Science - track 2:
- Digital health
- Vaccine technology
- Women's health
- Ageing research and microbiome
- Medtech
- Synthetic biology
Business and investment track:
- Keynote: A review of the life sciences investment landscape, with Q&A
- Panel Discussion: An Insight into the Macro Environmental Factors Impacting your Business
- Keynote: The Art of Dealmaking
- Keynote: The Humble CEO, What Makes a Winning Mindset
- Big Pharma Showcase
- Panel Discussion: An Insight into how the IRA & BioSecure Act in the US, Impact External Markets
- Panel Discussion: Working with a CRO to Minimise Risk & Maximise Success
- Keynote: London Stock Exchange, Understanding Market Differences
- Keynote: Driving Growth for the UK Life Sciences Sector
- Panel Discussion: An Insiders Guide to Mergers & Acquisitions
- Panel Discussion: A Review of the Latest Regulatory Updates Impacting R&D SME's
- Panel Discussion: ESG & Sustainability - How to Change your Business for the Better
- CEO Spotlight Session
BioTrinity is open to both OBN and Non-OBN members. Life sciences organizations from Vienna are invited to reach out to LISAvienna for a 15% discount code.